Parity-Dependent Recognition of DBL1X-3X Suggests an Important Role of the VAR2CSA High-Affinity CSA-Binding Region in the Development of the Humoral Response against Placental Malaria

ABSTRACT Plasmodium falciparum multidomain protein VAR2CSA stands today as the leading vaccine candidate against pregnancy-associated malaria (PAM). Most of the studies aiming to decrypt how naturally acquired immunity develops have assessed the immune recognition of individual VAR2CSA Duffy-binding-like (DBL) domains, thus overlooking the presence of conformational epitopes resulting from the overall folding of the full-length protein. In order to characterize the development of humoral immunity toward VAR2CSA, we made use of a large cohort of 293 Senegalese pregnant women to assess the level of recognition by plasma IgG of the full-length VAR2CSA protein of the 3D7 parasite strain (3D7-VAR2CSA), the CSA-binding multidomains 3D7-DBL1X to -DBL3X (3D7-DBL1X-3X), and the CSA nonbinding multidomains 3D7-DBL4ε to -DBL6ε (3D7-DBL4ε-6ε), as well as individual 3D7-DBL domains. Our results revealed a parity-dependent recognition of the full-length 3D7-VAR2CSA and of the CSA-binding region, 3D7-DBL1X-3X. Indeed, multigravid women possess significantly higher levels of antibodies directed against these constructs than primigravidae. Our results suggest an important role of antibodies targeting the CSA-binding region in the development of immunity against PAM, therefore providing new insights on how natural protection might be acquired and further information for the design of VAR2CSA-based vaccines.

[1]  K. Kain,et al.  Functional Antibodies against VAR2CSA in Nonpregnant Populations from Colombia Exposed to Plasmodium falciparum and Plasmodium vivax , 2014, Infection and Immunity.

[2]  N. Tolia,et al.  A quantitative assay for binding and inhibition of Plasmodium falciparum Erythrocyte Binding Antigen 175 reveals high affinity binding depends on both DBL domains. , 2014, Protein expression and purification.

[3]  John J. Chen,et al.  The Antibody Response of Pregnant Cameroonian Women to VAR2CSA ID1-ID2a, a Small Recombinant Protein Containing the CSA-Binding Site , 2014, PloS one.

[4]  N. Tolia,et al.  Red Blood Cell Invasion by Plasmodium vivax: Structural Basis for DBP Engagement of DARC , 2014, PLoS pathogens.

[5]  Steven Johnson,et al.  Biochemical Analysis of the Plasmodium falciparum Erythrocyte-binding Antigen-175 (EBA175)-Glycophorin-A Interaction , 2013, The Journal of Biological Chemistry.

[6]  P. Bigey,et al.  First-trimester Plasmodium falciparum infections display a typical "placental" phenotype. , 2012, The Journal of infectious diseases.

[7]  Joseph D. Smith,et al.  High Avidity Antibodies to Full-Length VAR2CSA Correlate with Absence of Placental Malaria , 2012, PloS one.

[8]  T. Theander,et al.  Structural and Functional Insight into How the Plasmodium falciparum VAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria* , 2012, The Journal of Biological Chemistry.

[9]  Joseph D. Smith,et al.  High Levels of Antibodies to Multiple Domains and Strains of VAR2CSA Correlate with the Absence of Placental Malaria in Cameroonian Women Living in an Area of High Plasmodium falciparum Transmission , 2012, Infection and Immunity.

[10]  A. Oleinikov,et al.  A Plasma Survey Using 38 PfEMP1 Domains Reveals Frequent Recognition of the Plasmodium falciparum Antigen VAR2CSA among Young Tanzanian Children , 2012, PloS one.

[11]  A. Taylor-Robinson,et al.  Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites , 2012, Malaria research and treatment.

[12]  B. Gamain,et al.  Var2CSA Minimal CSA Binding Region Is Located within the N-Terminal Region , 2011, PloS one.

[13]  N. Tolia,et al.  Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC , 2011, Nature Structural &Molecular Biology.

[14]  T. Theander,et al.  The Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains , 2011, The Journal of Biological Chemistry.

[15]  T. Theander,et al.  Full-Length Recombinant Plasmodium falciparum VAR2CSA Binds Specifically to CSPG and Induces Potent Parasite Adhesion-Blocking Antibodies , 2010, Journal of molecular biology.

[16]  B. Gamain,et al.  Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA , 2010, Proceedings of the National Academy of Sciences.

[17]  M. Wahlgren,et al.  Differential Recognition of P. falciparum VAR2CSA Domains by Naturally Acquired Antibodies in Pregnant Women from a Malaria Endemic Area , 2010, PloS one.

[18]  M. Higgins,et al.  Structural Comparison of Two CSPG-Binding DBL Domains from the VAR2CSA Protein Important in Malaria during Pregnancy , 2009, Journal of molecular biology.

[19]  Louise A Kelly-Hope,et al.  The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa , 2009, Malaria Journal.

[20]  A. Gittis,et al.  Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A , 2008, Nature Structural &Molecular Biology.

[21]  M. Higgins,et al.  The Structure of a Chondroitin Sulfate-binding Domain Important in Placental Malaria , 2008, Journal of Biological Chemistry.

[22]  P. Deloron,et al.  Differential evolution of anti-VAR2CSA- IgG3 in primigravidae and multigravidae pregnant women infected by Plasmodium falciparum , 2008, Malaria Journal.

[23]  L. Hviid,et al.  VAR2CSA and protective immunity against pregnancy-associated Plasmodium falciparum malaria , 2007, Parasitology.

[24]  A. Oleinikov,et al.  Effects of sex, parity, and sequence variation on seroreactivity to candidate pregnancy malaria vaccine antigens. , 2007, The Journal of infectious diseases.

[25]  F. T. Ter Kuile,et al.  Epidemiology and burden of malaria in pregnancy. , 2007, The Lancet. Infectious diseases.

[26]  B. Gamain,et al.  Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies. , 2006, Microbes and infection.

[27]  C. Chitnis,et al.  Immunogenicity of Duffy Binding-Like Domains That Bind Chondroitin Sulfate A and Protection against Pregnancy-Associated Malaria , 2006, Infection and Immunity.

[28]  T. Theander,et al.  Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. , 2006, The Journal of infectious diseases.

[29]  B. Kirkwood,et al.  Rapid Acquisition of Isolate-Specific Antibodies to Chondroitin Sulfate A-Adherent Plasmodium falciparum Isolates in Ghanaian Primigravidae , 2005, Infection and Immunity.

[30]  B. Gamain,et al.  Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. , 2005, The Journal of infectious diseases.

[31]  Thor G. Theander,et al.  Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria , 2004, The Journal of experimental medicine.

[32]  C. Menéndez,et al.  The sick placenta-the role of malaria. , 2004, Placenta.

[33]  Kevin Marsh,et al.  Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria , 2004, The Lancet.

[34]  M. Fried,et al.  Antibodies That Inhibit Plasmodium falciparum Adhesion to Chondroitin Sulfate A Are Associated with Increased Birth Weight and the Gestational Age of Newborns , 2003, Infection and Immunity.

[35]  Thomas Lavstsen,et al.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A‐adhering Plasmodium falciparum involved in pregnancy‐associated malaria , 2003, Molecular microbiology.

[36]  A. Saul,et al.  In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response , 2002, Infection and Immunity.

[37]  R. Leke,et al.  Acquisition and decay of antibodies to pregnancy-associated variant antigens on the surface of Plasmodium falciparum-infected erythrocytes that protect against placental parasitemia. , 2001, The Journal of infectious diseases.

[38]  T. Theander,et al.  Plasma Antibodies from Malaria-Exposed Pregnant Women Recognize Variant Surface Antigens on Plasmodium falciparum-Infected Erythrocytes in a Parity-Dependent Manner and Block Parasite Adhesion to Chondroitin Sulfate A1 , 2000, The Journal of Immunology.

[39]  François Nosten,et al.  Maternal antibodies block malaria , 1998, Nature.

[40]  D. Fontenille,et al.  La transmission du paludisme dans la zone de Niakhar, Sénégal , 1998 .

[41]  Patrick E. Duffy,et al.  Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta , 1996, Science.

[42]  B. Greenwood,et al.  Relationships between maternal malaria and malarial immune responses in mothers and neonates , 1995, Parasite immunology.

[43]  B. Gamain,et al.  Expressing full-length functional PfEMP1 proteins in the HEK293 expression system. , 2013, Methods in molecular biology.

[44]  Joseph Bockhorst,et al.  Structural Polymorphism and Diversifying Selection on the Pregnancy Malaria Vaccine Candidate Var2csa , 2007 .

[45]  J. Trape,et al.  [Malaria transmission in the rural zone of Niakhar, Senegal]. , 1998, Tropical medicine & international health : TM & IH.